Continuing Education credits for the Rocky Mountain Symposium are provided by HMP Education.
Additional credit applications and approvals are pending. This page will be updated upon approval.
Please contact info@HMPeducation.com for any specific requests or more information.
Rocky Mountain Symposium Audience
This activity has been designed to meet the educational needs of physicians, pharmacists, advanced practice registered nurses, registered nurses, social workers, addiction professionals, prevention professionals, health education specialists, certified counselors, and psychologists.
Joint Accreditation Statement
In support of improving patient care, HMP Eduction is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity has been approved to offer AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. PAs should only claim credit commensurate with the extent of their participation.
This continuing nursing education activity has been approved to offer continuing contact hours for nurse professionals.
HMP Education is approved by the American Psychological Association to sponsor continuing education for psychologists. HMP Education maintains responsibility for this program and its content.
Instructional Level: Advanced
Addiction Professionals (NAADAC)
This course has been approved by HMP Education, as a NAADAC-Approved Education Provider, to provide educational credits. NAADAC Provider #182840. HMP Education is responsible for all aspects of the programming.
Social Workers (ASWB ACE)
As a Jointly Accredited Provider, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. HMP Education maintains responsibility for this course.
This continuing pharmacy education activity has been approved to offer continuing contact hours for pharmacy professionals.
Rocky Mountain Symposium has been approved by NBCC for NBCC credit. Sessions approved for NBCC credit are clearly identified. HMP Education, LLC, is solely responsible for all aspects of the program. NBCC Approval No. SP-3988
The below sessions are approved for NBCC credit:
1. Pain and Addiction: Feeling Safe Enough to Heal (Dr. Les Arias and Dr. Mel Pol)
2. Sexual Boundary Violations by Professionals (Dr. Philip Hemphill)
3. Medication for Addiction Treatment (MAT): Current Trends and Controversies (Jake Nichols, PharmD)
4. Building the City of Solutions: Evaluating the Addiction Crisis Response in Huntington/Cabell County WV (Dr. Todd Davies)
5. The Integration of Spirituality and Psychotherapy: Ethical Obligations, Boundaries, and Creating a Holistic Setting for Change (Dr. Jack Perkins)
6. Addiction and Moral Injury (Dr. Dottie Greene)
7. Clinical and Ethical Issues in Managing Suicide Risk in People Using Substances (Dr. John O’Neill)
8. Health, Wellness, and Quality of Life Satisfaction Among Persons Receiving Medication for Opioid Use Disorder (Dr. Rhonda Patrick)
9. LGBTQ Treatment Approaches and the Influence of Developmental Trauma (John Sovec)
10. Addressing Trauma in Early Recovery (Terra Holbrook)
11. Expanding Recovery: A Somatic Integration (Dr. Meri Shadley and Kelli Grock)
12. Treating “Resistant” Clients: Effective Strategies for Responding to Challenging Clients: Part 1 (Dr. Bruce Fischer)
13. Treating “Resistant” Clients: Effective Strategies for Responding to Challenging Clients: Part 2 (Dr. Bruce Fischer)
14. Medication for Opioid Use Disorders (Dr. Alexis Ritvo)
15. After the Overdose: Clinicians’ Experiences of Client Opioid Overdose Death (Christian Williams)
16. Medications for Opioid Use Disorder Save Lives: Closing the Treatment Gap (Dr. Steven Proctor)
17. Wholehearted Journey to Ethics (Maeve O’Neill)
18. Evaluating the Use of a Digital Therapeutic to Improve Client Engagement and Access (Dr. Winnie Nagle and Dr. Jennifer Irvin)
19. Medication Assisted Therapy (MAT) and Transitions of Care in Opioid Use Disorder (Janet Wilkinson)
20. Working with Families Experiencing Substance Use Problems (Dr. James DiReda and Maureen Cavanaugh)
21. Working with Suicidal Clients: More than Just Creating Safety (Dr. Nicole Siegfried)
22. Aligning Clinical Best Practices and Documentation with Managed Care Requirements (David Nefussy and Lisa Blanchard)
23. Psilocybin-Assisted Therapy for Substance Use Disorders (Dr. Chris Stauffer)
24. Bringing Transparency to Treatment (Dr. Brian Dawson and Kate Olson)
25. Kids in Context: Organizational Readiness to Treat Adolescents with Substance Use and Other Behavioral Challenges (Dr. Katie Berry and Drew Dutton)
26. Protocol for Use of Buprenorphine Long-Acting Formulations (Dr. David Mathis)
27. Feeding the Recovery Brain: Effectively Using Amino Acid Therapy and the 5-Star Pro-Recovery Diet to Reduce Post-Acute Withdrawal and Cravings (Christina Veselak)
28. Clean, Sober, and Tobacco Free: Changing the Paradigm of Substance Use Treatment (Therese Shumaker)
29. Building Adolescent and Family Recovery Capital Through Developmentally Informed Community Supports (Dr. Emily Hennessy)
30. We Say Addiction Is a Family Disease! Is It? (Dr. Michael Barnes and Mary Woods)
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, identified those with the potential to compromise the goals and educational integrity of the education and mitigated any conflict of interest. Relevant relationships, or lack thereof, are shared with the learner.
Supported education has been independently peer-reviewed to validate contentand faculty with relevant relationships have attested that:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and nonpromotional.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Manager, Accreditation & Compliance, by phone at 609.671.1137, by email at sconforti@HMPeducation.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Manager, Accreditation & Compliance, will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation & Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609.371.1137, by email at gsellers@HMPeducation.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 770.751.7332 or 609.371.1137.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Applications for commercial support from healthcare related industries are pending. Commercial support will be acknowledged as it is received.